These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2438504)

  • 21. Antiarrhythmic and electrophysiologic actions of clofilium in experimental canine models.
    Kopia GA; Eller BT; Patterson E; Shea MJ; Lucchesi BR
    Eur J Pharmacol; 1985 Oct; 116(1-2):49-61. PubMed ID: 4054216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifibrillatory actions of nadolol.
    Patterson E; Lucchesi BR
    J Pharmacol Exp Ther; 1982 Oct; 223(1):144-52. PubMed ID: 6126580
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardioprotective and antiarrhythmic effects of beta-blockers, propranolol, bisoprolol, and nipradilol in a canine model of regional ischemia.
    Ogawa T; Hieda N; Sugiyama S; Ito T; Satake T; Ozawa T
    Heart Vessels; 1989; 5(1):10-6. PubMed ID: 2573596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiarrhythmic and antifibrillatory actions of the levo- and dextrorotatory isomers of sotalol.
    Lynch JJ; Wilber DJ; Montgomery DG; Hsieh TM; Patterson E; Lucchesi BR
    J Cardiovasc Pharmacol; 1984; 6(6):1132-41. PubMed ID: 6084771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-adrenergic influences in canine ischemic sudden death: effects of alpha 1-adrenoceptor blockade with prazosin.
    Wilber DJ; Lynch JJ; Montgomery DG; Lucchesi BR
    J Cardiovasc Pharmacol; 1987 Jul; 10(1):96-106. PubMed ID: 2441161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of carvedilol on left ventricular function and arrhythmias during repeated short-time myocardial ischemia in experimental pigs.
    Höher M; Friedrich M; Sommer T; Marten A; Ehmer B; Hombach V; Hirche H
    Z Kardiol; 1989; 78 Suppl 3():7-15. PubMed ID: 2573214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostacyclin prevents ventricular fibrillation in a canine model of sudden cardiac death.
    Fiedler VB; Mardin M
    Basic Res Cardiol; 1986; 81(1):40-53. PubMed ID: 3521579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiarrhythmic efficacy of combined I(Ks) and beta-adrenergic receptor blockade.
    Lynch JJ; Salata JJ; Wallace AA; Stump GL; Gilberto DB; Jahansouz H; Liverton NJ; Selnick HG; Claremon DA
    J Pharmacol Exp Ther; 2002 Jul; 302(1):283-9. PubMed ID: 12065728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidysrhythmic actions of meobentine sulfate.
    Zimmerman JM; Patterson E; Pitt B; Lucchesi B
    Am Heart J; 1984 Jun; 107(6):1117-24. PubMed ID: 6720538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of pimobendan (UD-CG 115 BS), a new positive inotropic agent, on ventricular tachycardia and ischemic ventricular fibrillation in a conscious canine model of recent myocardial infarction.
    Lynch JJ; Kitzen JM; Hoff PT; Lucchesi BR
    J Cardiovasc Pharmacol; 1988; 12(5):547-54. PubMed ID: 2468054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic ventricular tachyarrhythmias in the conscious dog: prevention by UM-272 (dimethylpropranolol).
    Patterson E; Lucchesi BR
    J Cardiovasc Pharmacol; 1981; 3(4):769-80. PubMed ID: 6167806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HBI-3000 prevents secondary sudden cardiac death.
    Lee JY; Lucchesi BR
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):453-9. PubMed ID: 23615576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alinidine reduces the incidence of ischemic ventricular fibrillation in a conscious canine model, a protective effect antagonized by overdrive atrial pacing.
    Uprichard AC; Chi LG; Lynch JJ; Driscoll EM; Frye JW; Lucchesi BR
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):475-82. PubMed ID: 2476629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiarrhythmic and general cardiovascular activity of the N,N-dimethylquaternary ammonium derivative of bunolol.
    Kaplan HR; Barker JW; Dugan D; Fox J; Giardino E
    Arch Int Pharmacodyn Ther; 1974 Jan; 207(1):28-43. PubMed ID: 4151048
    [No Abstract]   [Full Text] [Related]  

  • 35. Development of ventricular tachyarrhythmias in the conscious canine during the recovery phase of experimental ischemic injury: effect of bethanidine administration.
    Patterson E; Amalfitano DJ; Lucchesi BR
    J Cardiovasc Pharmacol; 1984; 6(3):470-5. PubMed ID: 6202974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug.
    Black SC; Butterfield JL; Lucchesi BR
    J Cardiovasc Pharmacol; 1993 Dec; 22(6):810-8. PubMed ID: 7509898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antifibrillatory actions of UK-68,798, a class III antiarrhythmic agent.
    Black SC; Chi LG; Mu DX; Lucchesi BR
    J Pharmacol Exp Ther; 1991 Aug; 258(2):416-23. PubMed ID: 1865349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure of lidocaine to suppress lethal ischemic ventricular arrhythmias in a canine model of previous myocardial infarction.
    Lynch JJ; Heaney LA; Wallace AA; Gehret JR; Stein RB
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):41-9. PubMed ID: 1696665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antiarrhythmic actions of intravenous and oral UM424 in postinfarction canine myocardium.
    Gibson JK; Patterson E; Lucchesi BR
    J Cardiovasc Pharmacol; 1985; 7(2):211-8. PubMed ID: 2581070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction.
    Vanoli E; De Ferrari GM; Stramba-Badiale M; Hull SS; Foreman RD; Schwartz PJ
    Circ Res; 1991 May; 68(5):1471-81. PubMed ID: 2019002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.